Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease

Name: Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease
Published: 2017
License: Public Domain

Akcea Therapeutics · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

cardiovascular-disease dyslipidemia

elevated lipoprotein(a), cardiovascular disease, ionis-apo(a)-lrx, akcea-apo(a)-lrx, dyslipidemia, dyslipoproteinemia, hyperlipidemia, hyperlipoproteinemia, hyperlipoproteinemia(a), hyperlipoproteinemia a, lipoprotein, lipoprotein(a)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 836398
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.